All the top Biotech & Pharma news in one daily newsletter.

What to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear from you!📣

(You can also reach out to me on LinkedIn)

Last thing - if you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

THE GOOD
Approvals & Labels

Atara Biotherapeutics nabs priority review for allogeneic T-cell platform
Allogeneic T-cell, post-transplant lymphoproliferative disease - Read more

THE GOOD
Business Development

SK Biopharmaceuticals wants to be Asia’s radiopharma leader, signs $571.5M biobucks deal for Full-Life Technologies candidate
Radiopharmaceuticals, cancer - Read more

Aclaris Therapeutics sale of Eli Lilly therapy royalties and milestones to OMERS Life Sciences for up to $31.5 Million
Small molecule, alopecia areata - Read more

THE GOOD
Clinical Trials

Roche budges into the weight loss arena, posts positive Ph1 results
Small molecule, obesity - Read more

Adverum Biotechnologies’ positive Ph2 data in wet AMD
Gene therapy, wet age-related macular degeneration (AMD) - Read more

4D Molecular Therapeutics touts positive Ph2 wet AMD data
Gene therapy, wet age-related macular degeneration (AMD) - Read more

Bayer’s Nuqeba smashes a 2nd pivotal trial
Small molecule, metastatic hormone-sensitive prostate cancer (mHSPC) - Read more

Holy Grail moves towards massive cancer screening blood test clinical study in the US and UK
Diagnostics, blood tests, cancer screening - Read more

THE GOOD
Company Launches

Briefly Bio makes a brief launch
Scientific collaboration, experiment reproducibility - Read more

THE GOOD
Earnings & Finances

Johnson & Johnson earnings keep things positive despite IRA outlook
Quarterly earnings, Inflation Reduction Act - Read more

CRO hVIVO posts record revenue in H1 2024
CRO, contract research organization - Read more

Pharnext takes unusual approach to drug pricing
Drug pricing, small molecule, drug combo - Read more

THE GOOD
Fundraises

NGM Biopharmaceuticals, now private, raises $122M
Recombinant protein, primary sclerosing cholangitis, hyperemesis gravidarum - Read more

CytoReason $80M raise
Computational disease models - Read more

BioProcess360 Partners launch dedicated Life Sciences investment fund
Venture capital, bioprocessing technologies - Read more

Renalys Pharma ¥6B ($3.8m) Series A
Small molecule, IgA nephropathy - Read more

Truvian Health $74M in funding
Automated blood tests, diagnostics - Read more

Integra Therapeutics receives up to €10.5M ($11.5M) via the European Innovation Council (EIC) Accelerator program
Gene therapy, gene writing, pediatric hepatic disease, LNP - Read more

Draupnir Bio €12M ($13M) raise
Small molecule, protein degradation - Read more

THE GOOD
Investments

Sanofi to more than double its workforce at Hyderabad site with $437M expansion - Read more

INCOG Biopharma to invest $125m, expand sterile injectables manufacturing capacity
CDMO, manufacturing - Read more

Grünenthal $87M investment in its Latin America production sites
Manufacturing, tablets - Read more

THE GOOD
IPOs

Actuate Therapeutics to actuate an IPO, aims for $50M raise
Small molecule, pancreatic cancer - Read more

THE GOOD
Partnerships

Univercells Technologies and the Gene Therapy Program at the University of Pennsylvania (GTP) expand partnership
Gene therapy, rare disease, manufacturing, scale-up - Read more

THE GOOD
Regulatory

FDA launches rare disease innovation hub - Read more

ENJOYING THESE NEWSLETTERS?
Consider an optional paid subscription.

It’s a lot of work to put together a daily newsletter, and it’s currently just me writing these things (+ one part-time contractor - no fancy editing team!).

If you’re getting value out of these daily compilations, please consider a paid subscription (only $5/month) to support my continued work on this project.

THE BAD
Company Shutdown

Back to the wardrode - Aslan Pharmaceuticals shutting down after running out of money
Monoclonal antibody, small molecule, atopic dermatitis - Read more

THE BAD
Layoffs

Caribou Therapeutics trims workforce by 12% (21 roles), discontinues CAR-NK R&D
Cell therapy, CAR-T, CAR-NK, cancer, autoimmune - Read more

THE BAD
Partnerships

Roche’s Genentech bails on Relay Therapeutics SHP2 inhibitor deal
Small molecule, cancer - Read more

THE BAD
Politics & Policy

“Big Three” PBMs get ready to face House Committee on Oversight and Accountability music
Pharmacy Benefit Manager, drug pricing - Read more

Merck & Co. wants some IRA certainty, ask for DC federal court decision “as soon as practicable”
Inflation Reduction Act, drug pricing - Read more [Paywall]

THE BAD
Research

Turns out that air pollution might not be good for your skin
Psoriasis, autoimmune - Read more

THE UGLY
Strategic Plans

Cassava Sciences upended again as CEO and SVP of Neuroscience (btw they’re married to each other) both resign
Alzheimer’s, fraud - Read more [Read more]

THE UGLY
Withdrawals & Recalls

Endo Pharmaceuticals voluntarily recalls a single lot of panic disorder drug due to dosage mislabel
Small molecule, panic disorder - Read more

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

Want to sponsor this newsletter and reach an audience of 550+ biotech and pharma professionals? Reach us here. 👍

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here.